Mondaq Asia Pacific - China: Food, Drugs, Healthcare, Life Sciences
DeHeng Law Offices
此等问题的正解且待新药法实施细则和《药品注册管理办法》修订来澄清。
DeHeng Law Offices
2019年8月26日,《药品管理法》经修订后通过,其中原法第三十九条第二款的"医疗单位临床急需或者个人自用进口的少量药品,按照国家有关规定
DeHeng Law Offices
近几个月来医疗器械行业内改革动作频频。医疗器械注册人制度试点扩大到21个省,有如释放行业创新活力的一剂良方,监管方通过将产研分开&#
Ropes & Gray LLP
After continuously reshaping the competitive landscape in the pharmaceutical industry for several years, the Chinese government finally shifted its attention to the medtech industry.
King & Capital Law Firm
近日,北京市京都律师事务所合伙人汤建彬律师承
DeHeng Law Offices
提出了"远程医疗会诊"的概念,远程医疗会诊是应用计算机及网络、通讯技术进行异地医疗咨询活动,属于医疗行为,必须在取得《医疗机构执&#
DeHeng Law Offices
在国家医疗体制改革、支持社会办医及医疗大健康产业飞速发展的背景下,医疗机构并购领域已成为传统医疗集团和各路产业资本(地产商、
Ropes & Gray LLP
China's State Council, the country's top administrative authority, released a new Regulation of Human Genetic Resources1 (the "Regulation") on May 28, 2019, to replace the tentative rules issued
Hogan Lovells
T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
Ropes & Gray LLP
On April 20, 2019, the Chinese government submitted a second draft of the Drug Administration Law of the People's Republic of China to the Standing Committee of the NPC for deliberation.
Toby Mak
Supply of generic drugs and their interaction with the patent system, like standards essential patents, present one of the international frontiers of patent protection.
Ropes & Gray LLP
China's drug and device regulator recently announced a set of rules signaling increased scrutiny of foreign drug and device companies.
IP March
The applicants shall ensure the completeness of clinical trial data.
AFD China
In addition to fines, perpetrators may also face criminal sentences.
Ropes & Gray LLP
The Measures clarify longstanding ambiguities regarding the scope of permitted telemedicine.
Ropes & Gray LLP
On March 17, 2018, the Chinese State Council passed the Scientific Data Administrative Measures (the "Measures") to standardize the management of scientific data at a national level.
Reed Smith (Worldwide)
Following the issuance of the "Opinions on Deepening the Reform of Examination and Approval System and Encouraging Innovation in the Industries of Pharmaceuticals and Medical Devices"
Ropes & Gray LLP
The current MDR requires medtech companies to either conduct clinical studies in China or submit clinical evaluation reports illustrating equivalence to previously approved products
Ropes & Gray LLP
In response to the central government's calling for a data protection mechanism,1 the China Drug Administration (the "CDA") ...
Ropes & Gray LLP
On March 17, China's highest legislative body, the National People's Congress, approved a sweeping government restructuring plan.
Most Popular Recent Articles
Ropes & Gray LLP
After continuously reshaping the competitive landscape in the pharmaceutical industry for several years, the Chinese government finally shifted its attention to the medtech industry.
DeHeng Law Offices
提出了"远程医疗会诊"的概念,远程医疗会诊是应用计算机及网络、通讯技术进行异地医疗咨询活动,属于医疗行为,必须在取得《医疗机构执&#
DeHeng Law Offices
在国家医疗体制改革、支持社会办医及医疗大健康产业飞速发展的背景下,医疗机构并购领域已成为传统医疗集团和各路产业资本(地产商、
King & Capital Law Firm
近日,北京市京都律师事务所合伙人汤建彬律师承
DeHeng Law Offices
近几个月来医疗器械行业内改革动作频频。医疗器械注册人制度试点扩大到21个省,有如释放行业创新活力的一剂良方,监管方通过将产研分开&#
A&Z Law Firm
Lately many restaurants in Shanghai have been broadcasting the work environment in the kitchen at their entrance (in real-time). What is that about?
Hogan Lovells
T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
Ropes & Gray LLP
On April 20, 2019, the Chinese government submitted a second draft of the Drug Administration Law of the People's Republic of China to the Standing Committee of the NPC for deliberation.
Ropes & Gray LLP
The current MDR requires medtech companies to either conduct clinical studies in China or submit clinical evaluation reports illustrating equivalence to previously approved products
A&Z Law Firm
On September 24th, Ding Jianhua, director of the China Food and Drug Administration (CFDA) Supervision Department, stated at the 2017 Chinese Pharmaceutical Entrepreneurs, Scientists...
Ropes & Gray LLP
China's State Council, the country's top administrative authority, released a new Regulation of Human Genetic Resources1 (the "Regulation") on May 28, 2019, to replace the tentative rules issued
Ropes & Gray LLP
The Measures clarify longstanding ambiguities regarding the scope of permitted telemedicine.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter